Published in Prostate on May 15, 2006
Nuclear hormone receptor corepressor promotes esophageal cancer cell invasion by transcriptional repression of interferon-γ-inducible protein 10 in a casein kinase 2-dependent manner. Mol Biol Cell (2012) 0.86
Extracellular Vesicles in Renal Pathophysiology. Front Mol Biosci (2017) 0.82
Ecto-protein kinases and phosphatases: an emerging field for translational medicine. J Transl Med (2014) 0.80
Extracellular vesicles in prostate cancer: new future clinical strategies? Biomed Res Int (2014) 0.78
Proteomic database mining opens up avenues utilizing extracellular protein phosphorylation for novel therapeutic applications. J Transl Med (2015) 0.77
Ectokinases as novel cancer markers and drug targets in cancer therapy. Cancer Med (2014) 0.77
The emergence of extracellular vesicles in urology: fertility, cancer, biomarkers and targeted pharmacotherapy. J Extracell Vesicles (2015) 0.75
Structures of complement component C3 provide insights into the function and evolution of immunity. Nature (2005) 4.01
Complement and coagulation: strangers or partners in crime? Trends Immunol (2007) 2.48
Two different durations of adjuvant therapy with intermediate-dose interferon alfa-2b in patients with high-risk melanoma (Nordic IFN trial): a randomised phase 3 trial. Lancet Oncol (2011) 2.32
Multiple recognition assay reveals prostasomes as promising plasma biomarkers for prostate cancer. Proc Natl Acad Sci U S A (2011) 2.14
Molecular intercommunication between the complement and coagulation systems. J Immunol (2010) 2.12
Tissue factor produced by the endocrine cells of the islets of Langerhans is associated with a negative outcome of clinical islet transplantation. Diabetes (2005) 1.96
[A nationwide study in primary health care: One out of four patients suffers from anxiety and depression]. Lakartidningen (2003) 1.96
The role of complement in biomaterial-induced inflammation. Mol Immunol (2006) 1.67
Cardiomyocyte microvesicles contain DNA/RNA and convey biological messages to target cells. PLoS One (2012) 1.67
Long-term idiotype vaccination combined with interleukin-12 (IL-12), or IL-12 and granulocyte macrophage colony-stimulating factor, in early-stage multiple myeloma patients. Clin Cancer Res (2007) 1.66
Evidence for a relation between the viral load and genotype and hepatitis C virus-specific T cell responses. J Hepatol (2004) 1.51
Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma. Radiother Oncol (2005) 1.45
Increased death risk and altered cancer incidence pattern in patients with isolated or combined autoimmune primary adrenocortical insufficiency. Clin Endocrinol (Oxf) (2008) 1.41
Are therapeutic human mesenchymal stromal cells compatible with human blood? Stem Cells (2012) 1.36
An international serum standard for application in assays to detect human complement activation products. Mol Immunol (2013) 1.34
Inflammatory mediators expressed in human islets of Langerhans: implications for islet transplantation. Biochem Biophys Res Commun (2003) 1.33
Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population. Ophthalmology (2005) 1.32
Can cells and biomaterials in therapeutic medicine be shielded from innate immune recognition? Trends Immunol (2010) 1.28
Formation of composite endothelial cell-mesenchymal stem cell islets: a novel approach to promote islet revascularization. Diabetes (2008) 1.26
Binding of C3 fragments on top of adsorbed plasma proteins during complement activation on a model biomaterial surface. Biomaterials (2005) 1.25
Islet surface heparinization prevents the instant blood-mediated inflammatory reaction in islet transplantation. Diabetes (2007) 1.24
Prevalence of adenomas and hyperplastic polyps in mismatch repair mutation carriers among CAPP2 participants: report by the colorectal adenoma/carcinoma prevention programme 2. J Clin Oncol (2008) 1.23
Do cryopreserved mesenchymal stromal cells display impaired immunomodulatory and therapeutic properties? Stem Cells (2014) 1.21
Optimal heparin surface concentration and antithrombin binding capacity as evaluated with human non-anticoagulated blood in vitro. J Biomed Mater Res A (2003) 1.19
Lessons from the recent Journal Citation Report figures. Ups J Med Sci (2010) 1.18
Glucagon-like peptide-1 (7-36) amide prevents the accumulation of pyruvate and lactate in the ischemic and non-ischemic porcine myocardium. Peptides (2003) 1.14
The tick-over theory revisited: formation and regulation of the soluble alternative complement C3 convertase (C3(H2O)Bb). Mol Immunol (2007) 1.14
C3 adsorbed to a polymer surface can form an initiating alternative pathway convertase. J Immunol (2002) 1.13
Dissecting the instant blood-mediated inflammatory reaction in islet xenotransplantation. Xenotransplantation (2008) 1.12
Insulin-heparin infusions peritransplant substantially improve single-donor clinical islet transplant success. Transplantation (2010) 1.10
Long-term incidence of hypothyroidism after radiotherapy in patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys (2004) 1.10
Impact of vaginal surgery on sexuality and quality of life in women with urinary incontinence or genital descensus. Acta Obstet Gynecol Scand (2005) 1.09
Incidence of uveal melanoma in Sweden from 1960 to 1998. Invest Ophthalmol Vis Sci (2002) 1.08
Compstatin: a C3-targeted complement inhibitor reaching its prime for bedside intervention. Eur J Clin Invest (2015) 1.08
Immune cell counts and risks of respiratory infections among infants exposed pre- and postnatally to organochlorine compounds: a prospective study. Environ Health (2008) 1.07
Positron emission tomography: a real-time tool to quantify early islet engraftment in a preclinical large animal model. Transplantation (2007) 1.05
Distinctive regulation of contact activation by antithrombin and C1-inhibitor on activated platelets and material surfaces. Biomaterials (2009) 1.03
Development of abdominal fat and incipient metabolic syndrome in young healthy men exposed to long-term stress. Nutr Metab Cardiovasc Dis (2006) 1.02
Innate immunity activation on biomaterial surfaces: a mechanistic model and coping strategies. Adv Drug Deliv Rev (2011) 1.01
Low molecular weight dextran sulfate prevents the instant blood-mediated inflammatory reaction induced by adult porcine islets. Transplantation (2004) 1.01
Natural killer (NK) cell function is a strong prognostic factor in colorectal carcinoma patients treated with the monoclonal antibody 17-1A. Int J Cancer (2003) 1.01
Risk perception after genetic counseling in patients with increased risk of cancer. Hered Cancer Clin Pract (2009) 1.00
Acute antibody-mediated complement activation mediates lysis of pancreatic islets cells and may cause tissue loss in clinical islet transplantation. Transplantation (2008) 1.00
Ezrin expression in prostate cancer and benign prostatic tissue. Eur Urol (2005) 1.00
Heat shock proteins 27, 60 and 70 as prognostic markers of prostate cancer. APMIS (2008) 0.99
The instant blood-mediated inflammatory reaction characterized in hepatocyte transplantation. Transplantation (2011) 0.99
Intra- and interobserver reproducibility of interpretation of immunohistochemical stains of prostate cancer. Virchows Arch (2009) 0.99
Mesenchymal stromal cells engage complement and complement receptor bearing innate effector cells to modulate immune responses. PLoS One (2011) 0.99
Ultrastructure of the secretion of prostasomes from benign and malignant epithelial cells in the prostate. Prostate (2002) 0.99
Complement analysis in the 21st century. Mol Immunol (2007) 0.98
Complement component C3 binds to activated normal platelets without preceding proteolytic activation and promotes binding to complement receptor 1. J Immunol (2010) 0.98
A substantial increase of the impact factor. Ups J Med Sci (2012) 0.98
The significance of serum CA 125 elevation in malignant and nonmalignant diseases. Gynecol Oncol (2002) 0.97
Human prostasomes contain chromosomal DNA. Prostate (2009) 0.96
Composite islet-endothelial cell grafts: a novel approach to counteract innate immunity in islet transplantation. Am J Transplant (2005) 0.96
Quartz crystal microbalance-with dissipation monitoring (QCM-D) for real time measurements of blood coagulation density and immune complement activation on artificial surfaces. Biosens Bioelectron (2004) 0.96
Protection of nonself surfaces from complement attack by factor H-binding peptides: implications for therapeutic medicine. J Immunol (2011) 0.96
Properdin in complement activation and tissue injury. Mol Immunol (2013) 0.95
Neuro- and cardioprotective effects of blockade of nitric oxide action by administration of methylene blue. Ann N Y Acad Sci (2007) 0.94
Energy metabolic changes in the early post-injury period following traumatic brain injury in rats. Neurochem Res (2006) 0.94
Lack of cytoplasmic ERK activation is an independent adverse prognostic factor in primary cutaneous melanoma. J Invest Dermatol (2008) 0.94
Prognostic significance of tumor iNOS and COX-2 in stage III malignant cutaneous melanoma. Cancer Immunol Immunother (2008) 0.94
Role of exosomes in myocardial remodeling. Circ Res (2014) 0.93
Preparatory studies of composite mesenchymal stem cell islets for application in intraportal islet transplantation. Ups J Med Sci (2010) 0.93
Nicotinamide inhibits tissue factor expression in isolated human pancreatic islets: implications for clinical islet transplantation. Transplantation (2003) 0.93
The role of whole blood in thrombin generation in contact with various titanium surfaces. Biomaterials (2006) 0.93
Platelets, complement, and contact activation: partners in inflammation and thrombosis. Adv Exp Med Biol (2012) 0.92
ABH blood group antigens in O-glycans of human glycophorin A. Arch Biochem Biophys (2004) 0.92
Breast cancer incidence and use of antihypertensive medication in women. Pharmacoepidemiol Drug Saf (2004) 0.92
Uveal melanoma: a study on incidence of additional cancers in the Swedish population. Invest Ophthalmol Vis Sci (2006) 0.92
Prostasomal DNA characterization and transfer into human sperm. Mol Reprod Dev (2011) 0.91
Prostasomes are heterogeneous regarding size and appearance but affiliated to one DNA-containing exosome family. Prostate (2012) 0.90
Evaluation of the blood compatibility of materials, cells, and tissues: basic concepts, test models, and practical guidelines. Adv Exp Med Biol (2013) 0.90
Regulated Extracellular Choline Acetyltransferase Activity- The Plausible Missing Link of the Distant Action of Acetylcholine in the Cholinergic Anti-Inflammatory Pathway. PLoS One (2013) 0.90
Hodgkin's lymphoma in the elderly with special reference to type and intensity of chemotherapy in relation to prognosis. Haematologica (2003) 0.90
Durable carcinoembryonic antigen (CEA)-specific humoral and cellular immune responses in colorectal carcinoma patients vaccinated with recombinant CEA and granulocyte/macrophage colony-stimulating factor. Clin Cancer Res (2004) 0.90
Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study. Eur J Haematol (2009) 0.89
Immune complex-mediated cytokine production is regulated by classical complement activation both in vivo and in vitro. Adv Exp Med Biol (2008) 0.89
Intraportal pig islet xenotransplantation into athymic mice as an in vivo model for the study of the instant blood-mediated inflammatory reaction. Xenotransplantation (2004) 0.89
Activated human platelets induce factor XIIa-mediated contact activation. Biochem Biophys Res Commun (2009) 0.89
Characteristics of human prostasomes isolated from three different sources. Prostate (2003) 0.89
Thrombotic disease in systemic lupus erythematosus is associated with a maintained systemic platelet activation. Br J Haematol (2004) 0.88
Prompt reversal of a severe complement activation by eculizumab in a patient undergoing intentional ABO-incompatible pancreas and kidney transplantation. Transpl Int (2011) 0.88
Proteomic analysis of prostate cancer metastasis-derived prostasomes. Anticancer Res (2010) 0.88
Towards therapeutic vaccines for colorectal carcinoma: a review of clinical trials. Expert Rev Vaccines (2005) 0.88
Systemic immune effects of adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide and/or radiotherapy in breast cancer: a longitudinal study. Cancer Immunol Immunother (2008) 0.88
Growth factor stimulation of cardiomyocytes induces changes in the transcriptional contents of secreted exosomes. J Extracell Vesicles (2013) 0.87
Metabolic manipulation of glioblastoma in vivo by retrograde microdialysis of L-2, 4 diaminobutyric acid (DAB). J Neurooncol (2006) 0.87